Sleep in Adolescents and Young Adults in the Year After Cancer Treatment

Sleep in Adolescents and Young Adults in the Year After Cancer Treatment
复制标题

DOI:
10.1089/jayao.2017.0006
复制
发表时间:
2017-12-01
影响因子:
2
通讯作者:
Schwartz, Lisa A.
Schwartz, Lisa A.
中科院分区:
医学4区
文献类型:
--
作者:
Daniel, Lauren C.;Aggarwal, Richa;Schwartz, Lisa A.

文献摘要

被引文献

相似文献

目的:患有癌症的青少年和年轻人(AYA)是一个弱势群体,相对于年幼的儿童,他们面临更密集的治疗,更高的症状负担和更差的治疗结果。睡眠中断在癌症治疗期间很常见,对于一些AYA癌症的幸存者来说,睡眠问题一直持续到成年。青春期/成年初显期的发育期相对于较年长或较年轻的年龄而言,睡眠不足的生物和行为风险更大。因此,了解AYA睡眠障碍后不久完成治疗可以通知干预措施,以管理癌症相关的症状,提高生活quality.Methods:六十一AYA(年龄12-25岁)在1年内完成癌症治疗匹兹堡睡眠质量指数(PSQI)和明尼阿波利斯-曼彻斯特生活质量工具,青少年形式。结果:47%的参与者被归类为“睡眠不佳者”,41%的人报告睡眠潜伏期延长(>30分钟),31%的人报告睡眠效率提示失眠,33%的人睡眠不足。
Purpose: Adolescents and young adults (AYA) with cancer are a vulnerable group facing more intense treatments, higher symptom burden, and poorer treatment outcomes relative to younger children. Sleep disruption is common during cancer treatment and sleep problems persist into adulthood for some survivors of AYA cancer. The developmental period of adolescence/emerging adulthood confers greater biological and behavioral risk for insufficient sleep relative to older or younger ages. Thus, understanding AYA sleep disturbances shortly after completing treatment can inform interventions to manage cancer-related symptoms and improve quality of life.Methods: Sixty-one AYA (ages 12-25) within 1 year of finishing cancer treatment completed the Pittsburgh Sleep Quality Index (PSQI) and the Minneapolis-Manchester Quality of Life Instrument-Adolescent Form. Treatment variables were extracted from electronic medical records.Results: Forty-seven percent of participants were classified as "poor sleepers,'' 41% reported prolonged sleep onset latency (>30 minutes), 31% reported sleep efficiency suggestive of insomnia, and 33% slept